1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Insulin Glargine 1.2.3 Insulin Determir 1.2.4 Insulin Degludec 1.2.5 Long Acting Animal Insulin 1.3 Market by Application 1.3.1 Global Long Acting Insulins Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Home Use 1.3.3 Medical Institutions 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Long Acting Insulins Market Perspective (2016-2027) 2.2 Long Acting Insulins Growth Trends by Regions 2.2.1 Long Acting Insulins Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Long Acting Insulins Historic Market Share by Regions (2016-2021) 2.2.3 Long Acting Insulins Forecasted Market Size by Regions (2022-2027) 2.3 Long Acting Insulins Industry Dynamic 2.3.1 Long Acting Insulins Market Trends 2.3.2 Long Acting Insulins Market Drivers 2.3.3 Long Acting Insulins Market Challenges 2.3.4 Long Acting Insulins Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Long Acting Insulins Players by Revenue 3.1.1 Global Top Long Acting Insulins Players by Revenue (2016-2021) 3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2016-2021) 3.2 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Long Acting Insulins Revenue 3.4 Global Long Acting Insulins Market Concentration Ratio 3.4.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2020 3.5 Long Acting Insulins Key Players Head office and Area Served 3.6 Key Players Long Acting Insulins Product Solution and Service 3.7 Date of Enter into Long Acting Insulins Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Long Acting Insulins Breakdown Data by Type 4.1 Global Long Acting Insulins Historic Market Size by Type (2016-2021) 4.2 Global Long Acting Insulins Forecasted Market Size by Type (2022-2027) 5 Long Acting Insulins Breakdown Data by Application 5.1 Global Long Acting Insulins Historic Market Size by Application (2016-2021) 5.2 Global Long Acting Insulins Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Long Acting Insulins Market Size (2016-2027) 6.2 North America Long Acting Insulins Market Size by Type 6.2.1 North America Long Acting Insulins Market Size by Type (2016-2021) 6.2.2 North America Long Acting Insulins Market Size by Type (2022-2027) 6.2.3 North America Long Acting Insulins Market Size by Type (2016-2027) 6.3 North America Long Acting Insulins Market Size by Application 6.3.1 North America Long Acting Insulins Market Size by Application (2016-2021) 6.3.2 North America Long Acting Insulins Market Size by Application (2022-2027) 6.3.3 North America Long Acting Insulins Market Size by Application (2016-2027) 6.4 North America Long Acting Insulins Market Size by Country 6.4.1 North America Long Acting Insulins Market Size by Country (2016-2021) 6.4.2 North America Long Acting Insulins Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Long Acting Insulins Market Size (2016-2027) 7.2 Europe Long Acting Insulins Market Size by Type 7.2.1 Europe Long Acting Insulins Market Size by Type (2016-2021) 7.2.2 Europe Long Acting Insulins Market Size by Type (2022-2027) 7.2.3 Europe Long Acting Insulins Market Size by Type (2016-2027) 7.3 Europe Long Acting Insulins Market Size by Application 7.3.1 Europe Long Acting Insulins Market Size by Application (2016-2021) 7.3.2 Europe Long Acting Insulins Market Size by Application (2022-2027) 7.3.3 Europe Long Acting Insulins Market Size by Application (2016-2027) 7.4 Europe Long Acting Insulins Market Size by Country 7.4.1 Europe Long Acting Insulins Market Size by Country (2016-2021) 7.4.2 Europe Long Acting Insulins Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Long Acting Insulins Market Size (2016-2027) 8.2 Asia-Pacific Long Acting Insulins Market Size by Type 8.2.1 Asia-Pacific Long Acting Insulins Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Long Acting Insulins Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Long Acting Insulins Market Size by Type (2016-2027) 8.3 Asia-Pacific Long Acting Insulins Market Size by Application 8.3.1 Asia-Pacific Long Acting Insulins Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Long Acting Insulins Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Long Acting Insulins Market Size by Application (2016-2027) 8.4 Asia-Pacific Long Acting Insulins Market Size by Region 8.4.1 Asia-Pacific Long Acting Insulins Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Long Acting Insulins Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Long Acting Insulins Market Size (2016-2027) 9.2 Latin America Long Acting Insulins Market Size by Type 9.2.1 Latin America Long Acting Insulins Market Size by Type (2016-2021) 9.2.2 Latin America Long Acting Insulins Market Size by Type (2022-2027) 9.2.3 Latin America Long Acting Insulins Market Size by Type (2016-2027) 9.3 Latin America Long Acting Insulins Market Size by Application 9.3.1 Latin America Long Acting Insulins Market Size by Application (2016-2021) 9.3.2 Latin America Long Acting Insulins Market Size by Application (2022-2027) 9.3.3 Latin America Long Acting Insulins Market Size by Application (2016-2027) 9.4 Latin America Long Acting Insulins Market Size by Country 9.4.1 Latin America Long Acting Insulins Market Size by Country (2016-2021) 9.4.2 Latin America Long Acting Insulins Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Long Acting Insulins Market Size (2016-2027) 10.2 Middle East & Africa Long Acting Insulins Market Size by Type 10.2.1 Middle East & Africa Long Acting Insulins Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Long Acting Insulins Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Long Acting Insulins Market Size by Type (2016-2027) 10.3 Middle East & Africa Long Acting Insulins Market Size by Application 10.3.1 Middle East & Africa Long Acting Insulins Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Long Acting Insulins Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Long Acting Insulins Market Size by Application (2016-2027) 10.4 Middle East & Africa Long Acting Insulins Market Size by Country 10.4.1 Middle East & Africa Long Acting Insulins Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Long Acting Insulins Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novo Nordisk 11.1.1 Novo Nordisk Company Details 11.1.2 Novo Nordisk Business Overview 11.1.3 Novo Nordisk Long Acting Insulins Introduction 11.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2016-2021) 11.1.5 Novo Nordisk Recent Development 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Long Acting Insulins Introduction 11.2.4 Sanofi Revenue in Long Acting Insulins Business (2016-2021) 11.2.5 Sanofi Recent Development 11.3 Wockhardt UK 11.3.1 Wockhardt UK Company Details 11.3.2 Wockhardt UK Business Overview 11.3.3 Wockhardt UK Long Acting Insulins Introduction 11.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2016-2021) 11.3.5 Wockhardt UK Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Insulin Glargine Table 3. Key Players of Insulin Determir Table 4. Key Players of Insulin Degludec Table 5. Key Players of Long Acting Animal Insulin Table 6. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Long Acting Insulins Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Long Acting Insulins Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Long Acting Insulins Market Share by Regions (2016-2021) Table 10. Global Long Acting Insulins Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Long Acting Insulins Market Share by Regions (2022-2027) Table 12. Long Acting Insulins Market Trends Table 13. Long Acting Insulins Market Drivers Table 14. Long Acting Insulins Market Challenges Table 15. Long Acting Insulins Market Restraints Table 16. Global Long Acting Insulins Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Long Acting Insulins Market Share by Players (2016-2021) Table 18. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2020) Table 19. Ranking of Global Top Long Acting Insulins Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Long Acting Insulins Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Long Acting Insulins Product Solution and Service Table 23. Date of Enter into Long Acting Insulins Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Long Acting Insulins Market Size by Type (2016-2021) (US$ Million) Table 26. Global Long Acting Insulins Revenue Market Share by Type (2016-2021) Table 27. Global Long Acting Insulins Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Long Acting Insulins Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Long Acting Insulins Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Long Acting Insulins Revenue Market Share by Application (2016-2021) Table 31. Global Long Acting Insulins Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Long Acting Insulins Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Long Acting Insulins Market Size by Type (2016-2021) (US$ Million) Table 34. North America Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Long Acting Insulins Market Size by Application (2016-2021) (US$ Million) Table 36. North America Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Long Acting Insulins Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Long Acting Insulins Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Long Acting Insulins Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Long Acting Insulins Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Long Acting Insulins Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Long Acting Insulins Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Long Acting Insulins Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Long Acting Insulins Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Long Acting Insulins Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Long Acting Insulins Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Long Acting Insulins Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Long Acting Insulins Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Long Acting Insulins Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Long Acting Insulins Market Size by Country (2022-2027) & (US$ Million) Table 63. Novo Nordisk Company Details Table 64. Novo Nordisk Business Overview Table 65. Novo Nordisk Long Acting Insulins Product Table 66. Novo Nordisk Revenue in Long Acting Insulins Business (2016-2021) & (US$ Million) Table 67. Novo Nordisk Recent Development Table 68. Sanofi Company Details Table 69. Sanofi Business Overview Table 70. Sanofi Long Acting Insulins Product Table 71. Sanofi Revenue in Long Acting Insulins Business (2016-2021) & (US$ Million) Table 72. Sanofi Recent Development Table 73. Wockhardt UK Company Details Table 74. Wockhardt UK Business Overview Table 75. Wockhardt UK Long Acting Insulins Product Table 76. Wockhardt UK Revenue in Long Acting Insulins Business (2016-2021) & (US$ Million) Table 77. Wockhardt UK Recent Development Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Global Long Acting Insulins Market Share by Type: 2020 VS 2027 Figure 2. Insulin Glargine Features Figure 3. Insulin Determir Features Figure 4. Insulin Degludec Features Figure 5. Long Acting Animal Insulin Features Figure 6. Global Long Acting Insulins Market Share by Application: 2020 VS 2027 Figure 7. Home Use Case Studies Figure 8. Medical Institutions Case Studies Figure 9. Others Case Studies Figure 10. Long Acting Insulins Report Years Considered Figure 11. Global Long Acting Insulins Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Long Acting Insulins Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Long Acting Insulins Market Share by Regions: 2020 VS 2027 Figure 14. Global Long Acting Insulins Market Share by Regions (2022-2027) Figure 15. Global Long Acting Insulins Market Share by Players in 2020 Figure 16. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2020 Figure 18. Global Long Acting Insulins Revenue Market Share by Type (2016-2021) Figure 19. Global Long Acting Insulins Revenue Market Share by Type (2022-2027) Figure 20. North America Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Long Acting Insulins Market Share by Type (2016-2027) Figure 22. North America Long Acting Insulins Market Share by Application (2016-2027) Figure 23. North America Long Acting Insulins Market Share by Country (2016-2027) Figure 24. United States Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Long Acting Insulins Market Share by Type (2016-2027) Figure 28. Europe Long Acting Insulins Market Share by Application (2016-2027) Figure 29. Europe Long Acting Insulins Market Share by Country (2016-2027) Figure 30. Germany Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Long Acting Insulins Market Share by Type (2016-2027) Figure 38. Asia-Pacific Long Acting Insulins Market Share by Application (2016-2027) Figure 39. Asia-Pacific Long Acting Insulins Market Share by Region (2016-2027) Figure 40. China Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Long Acting Insulins Market Share by Type (2016-2027) Figure 48. Latin America Long Acting Insulins Market Share by Application (2016-2027) Figure 49. Latin America Long Acting Insulins Market Share by Country (2016-2027) Figure 50. Mexico Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Long Acting Insulins Market Share by Type (2016-2027) Figure 54. Middle East & Africa Long Acting Insulins Market Share by Application (2016-2027) Figure 55. Middle East & Africa Long Acting Insulins Market Share by Country (2016-2027) Figure 56. Turkey Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Long Acting Insulins Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2016-2021) Figure 60. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2016-2021) Figure 61. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2016-2021) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Novo Nordisk Sanofi Wockhardt UK